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98elays in widespread adoption of new knowledge in health
are are common. More than 10 years after the demonstra-
ion that beta-blocker treatment confers a survival advantage
o patients who survived an acute myocardial infarction,
eta-blocker drugs were prescribed for only about one-half
f these patients (1). Similar observations have been made
or many other treatments (2–7). A principal challenge in
edicine is to accelerate the adoption of guideline-based
ecommendations and close the gap between ideal practice
nd usual practice.
See page 105
Door-to-balloon (D2B) time, the time between hospital
rrival and primary percutaneous coronary intervention
PCI) for patients with ST-segment elevation myocardial
infarction (STEMI), is strongly
associated with the likelihood
of survival and is an accepted
measure of quality of care. The
majority of patients are not
treated within the guideline-
recommended D2B time of 90
min or less (8), despite its im-
portance. Moreover, even as
other quality indicators have
improved, D2B times at hospi-
tals across the U.S. have not
decreased substantially (9).
Recent research has revealed
key strategies that are associated
with faster D2B times, demon-
strating how best to achieve out-
standing performance (10–13).
This paper describes the ratio-
nale and methods of D2B: An
Alliance for Quality, an effort
organized by the American
ollege of Cardiology (ACC) in partnership with the
merican Heart Association (AHA) and 37 other orga-
izations to rapidly translate the research about how best
o achieve outstanding D2B times for patients with
TEMI into practice. The effort began with a focus on
he U.S. but has a growing number of international
articipants.
ackground
any studies have demonstrated a continuous relationship
etween shorter D2B times and better survival for patients
ith STEMI who undergo primary PCI (14–18). Primary
CI has become the preferred method for reperfusion
bbreviations
nd Acronyms
CC  American College of
ardiology
CTION  Acute Coronary
reatment and Intervention
utcomes Network
HA  American Heart
ssociation
MS  Centers for Medicare
Medicaid Services
2B  door-to-balloon
CDR  National
ardiovascular Data Registry
HLBI  National Heart,
ung, and Blood Institute
CI  percutaneous
oronary intervention
TEMI  ST-segment
levation myocardial
nfarctionherapy over fibrinolytic therapy in hospitals with primary DCI capability. This strategy is supported by a meta-analysis
f 23 trials showing an absolute 2% reduction in mortality
ith primary PCI compared with fibrinolytic therapy (19).
urther analysis, on the basis of the results of randomized
rials comparing primary PCI and fibrinolytic therapy for
atients with STEMI, demonstrates that when the time to
erform primary PCI exceeds the time to administer fi-
rinolytic therapy by approximately 60 to 100 min, the
dvantage of primary PCI might be markedly attenuated or
liminated. The ACC/AHA Guidelines recommend that
ospitals perform primary PCI for patients with STEMI in
0 min or less (20). Nevertheless, many patients experience
elays in treatment, with the vast majority receiving treat-
ent in excess of 90 min. In an investigation using the
ational Registry of Myocardial Infarction database, ap-
roximately two-thirds of patients were treated with times
onger than 90 min, with one-third treated with times that
xceeded 120 min (17).
Despite contemporary national data showing that many
atients undergoing primary PCI are not treated within 90
in, some hospitals consistently achieve D2B times of 90
in or less for their patients. This observation led to a
ational Heart, Lung, and Blood Institute (NHLBI)–
ponsored investigation of how the best-performing hospi-
als achieve their results. This research revealed a set of
trategies that top-performing hospitals used to achieve
uideline-based D2B times.
The NHLBI study employed a mixed methods approach,
ombining qualitative and quantitative research, to identify
trategies that differentiated the top-performing hospitals.
ualitative research revealed 8 themes that emerged from
nterviews at 11 top hospitals (10). These themes included a
ommitment to an explicit goal to improve D2B times
otivated by internal and external pressures, senior man-
gement support, innovative protocols, flexibility in refining
tandardized protocols, uncompromising individual clinical
eaders, collaborative teams, data feedback to monitor
rogress and identify problems and successes, and an orga-
izational culture that fostered resilience to challenges or
etbacks in improvement efforts. The experiences of the top
ospitals were used to develop flow diagrams and bench-
ark times that represent what can be achieved (12) as well
s hypotheses about the strategies most strongly associated
ith faster D2B times.
Quantitative research was then used to test hypotheses
rom the qualitative work in a national sample of hospitals
erforming PCI to evaluate the magnitude and statistical
ignificance of effects on D2B time. This research was
ccomplished with a survey of hospitals that perform pri-
ary PCI and submit publicly reported data to the Centers
or Medicare & Medicaid Services (CMS) (11). The strat-
gies with substantial and significant associations with faster
2B times were: 1) having emergency medicine physicians
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99ctivate the catheterization laboratory; 2) having a single call
o a central page operator to activate the laboratory; 3)
aving the emergency department activate the catheteriza-
ion laboratory while the patient is en route to the hospital
n the basis of a pre-hospital electrocardiogram; 4) expect-
ng staff to arrive in the catheterization laboratory within 20
o 30 min (vs. 30 min) after being paged; 5) having an
ttending cardiologist always on site; and 6) having staff
n the emergency department and the catheterization
aboratory use real-time data feedback. Despite the
trong association of these strategies with faster times,
owever, only a minority of the hospitals surveyed were
sing them.
Thus, research showed that many patients do not receive
imely primary PCI and identified underused strategies that
re associated with shorter times at top-performing institu-
ions. With this knowledge, the challenge was to develop an
pproach to disseminate best practice into routine practice,
fficiently and effectively apply the approach in the U.S. and
hen internationally, and improve the timeliness of primary
CI for patients with STEMI.
he D2B Alliance
he D2B Alliance, initiated by the ACC and comprising a
roup of international organizations, clinicians, and hospi-
als, was developed to improve D2B times for patients with
TEMI undergoing primary PCI. An overview of the
imeline is shown in Figure 1. The goal of the D2B Alliance
Figure 1. D2B Key Milestones and TimelineACC  American College of Cardiology; AHA  American Heart Association; D2B s for participating hospitals to treat 75% of their nontrans-
er patients with STEMI receiving PCI within 90 min or
ess of hospital arrival.
The D2B Alliance was based on the following principles:
) Treatment of patients within the guideline recommen-
dations was feasible
) Strong empirical evidence supports the effectiveness of
specific strategies for reducing D2B time
) Evidence-based strategies could be widely and rapidly
adopted, changing the way care is delivered
) Innovations shared among institutions would accelerate
rapid improvements
) Partnerships across the spectrum of organizations with
an interest in outstanding care for patients with STEMI
would support and sustain the effort
) The initiative could be practical and accomplished effi-
ciently with a minimum investment by hospitals
irst phase—planning. The D2B Alliance was conceived in
anuary 2006; the effort was divided into 4 distinct phases.
irst, in the planning phase, several working groups were
stablished. The groups included volunteers and ACC staff
epresenting a wide range of expertise, including perspec-
ives from quality improvement, cardiology, emergency
edicine, nursing, and hospital management. An evidence
orkgroup performed a systematic review of the published
eports on improving D2B times and helped establish the
ore processes that would be promoted (21). A toolkitdoor-to-balloon.
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100orkgroup reviewed various tools and identified examples of
hose that would assist clinicians and hospitals (Online
ppendix). A change package workgroup focused on rec-
mmendations for creating an environment that would
oster a commitment to the goal of the D2B Alliance. A
orkgroup, focused on awarding credits for recertification
nd continuing medical education, developed a module in
ollaboration with the American Board of Internal Medi-
ine. An evaluation workgroup developed a plan to assess
he overall impact of the effort.
During the planning phase, national organizations were
ncouraged to join the D2B Alliance. Although managed
nd entirely funded by the ACC, the D2B Alliance was
eveloped as a truly collaborative effort among many orga-
izations. The partners would promote the D2B Alliance
nd, in some cases, participate actively with hospitals to help
hem achieve better performance. Because the achievement
f outstanding D2B times requires teamwork, the enlisting
f a diverse group of partners—including the AHA; various
mergency medicine organizations; the NHLBI; the
gency for Healthcare Research and Quality; and others—
as considered essential to the success of the project. There
re now 38 collaborating organizations (Table 1).
Also in the planning phase, the intervention was devel-
ped and involved a number of key features. First, as a
ondition of enrollment, a hospital’s administration was
equired to commit to reaching the performance goal of the
roject. Second, upon enrollment, participating hospitals
eceived a toolkit and change packet that provided a
tep-by-step approach to reduce D2B times rooted in
ecently published evidence (10,11,13). Specifically, hospi-
als were strongly encouraged to implement evidence-based
trategies to improve times. Third, at the time of enroll-
ent, participating hospitals used a Web-based survey
Online Appendix) to complete a baseline assessment of
heir current use of key strategies that are pertinent to D2B
imes. Fourth, these survey data were analyzed and com-
ared with the recommended approach to reducing D2B
ime as evidenced in the literature, and hospitals were given
ndividually tailored “action plans” to reduce D2B times.
ifth, hospitals were offered common educational initia-
ives, including D2B Alliance workshops, Web-based sem-
nars, and access to an online community of all participating
ospitals. Sixth, the D2B Alliance partners, such as the
HA, Tenet, Hospital Corporation of America, VHA,
nc., Premier, Inc., as well as ACC local organizations
chapters) serving almost every state, were supported in their
fforts to publicize the initiative and assist hospitals in their
fforts to make improvements. The ACC chapters are a
ritical component of the D2B Alliance because they involve
strong network of physician champions in each state who
an motivate and facilitate changes at the hospital and
hysician level. sA systematic review of the published data (21) on
mproving D2B times identified several key strategies that
ere considered for inclusion in the initiative. With these
ndings, the D2B Alliance focused on the most potent
trategies that could be implemented inexpensively and
apidly by every hospital. The key strategies chosen by the
2B Alliance are shown in Table 2 and include having the
mergency medicine physician activate the catheterization
aboratory with a single call, having the team prepared
ithin 20 to 30 min of the call, rapid data feedback, a
eam-based approach, and administrative support. The use
f a pre-hospital electrocardiogram by emergency medical
Table 1. D2B Alliance Strategic Partners
Collaborator*
American Heart Association
BlueCross BlueShield Association and participating companies
Christiana Care Health System
Expecting Success
Hospital Corporation of America
Novant Health
Prairie Cardiovascular
Saint Barnabas Health Care System
The Society for Cardiovascular Angiography and Interventions
Society of Chest Pain Centers
South Carolina Hospital Association
Tenet Healthcare
UnitedHealthcare
University HealthSystem Consortium
VHA, Inc.
WellPoint
Sponsor†
Aetna
American College of Cardiovascular Administrators
American College of Emergency Physicians
Emergency Medicine Cardiac Research and Education Group
Florida Quality Improvement Organization
Institute for Healthcare Improvement
Premier, Inc.
Visionary supporter‡
Agency for Healthcare Research and Quality
Alliance for Cardiac Care Excellence
American Academy of Emergency Medicine
The Joint Commission
American Health Quality Association
National Association of EMS Physicians
National Heart, Lung, and Blood Institute
Society for Academic Emergency Medicine
*Institutions that agree to publicly endorse and actively promote door-to-balloon (D2B), permit
the American College of Cardiology to use their logo and name in promotional efforts, and
commit to a recruitment goal related to D2B participation of 20% of primary percutaneous
coronary intervention hospitals in their network. †Institutions that agree to publicly endorse and
actively promote D2B and permit the American College of Cardiology to use their logo and
name in promotional efforts. ‡Institutions that agree to publicly endorse D2B but do not
actively engage in promotion.ervices personnel to activate the catheterization laboratory
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101as noted as an additional optional strategy. Recognizing
hat activation on the basis of a pre-hospital electrocardio-
ram might be particularly challenging and not fully within
hospital’s control, the D2B Alliance did not include this
trategy as a core strategy despite its strong association with
horter D2B times. Other strategies, such as having a
ardiologist in the hospital at all times, were controversial
nd/or costly and complex to implement and therefore were
ot incorporated into the core recommendations of the
ampaign even though they had been identified as having a
trong association with faster times.
Data submission requirements for the project were inten-
ionally minimal in an effort to reduce the barriers to
nrollment in the D2B Alliance. Because hospitals have
any options to collect and report data, the initiative chose
o afford hospitals maximum flexibility on how to collect
erformance data for internal data feedback. For the pur-
ose of the project, hospitals were encouraged to measure
imes with standards established by the CMS for D2B time
ncluded in the Hospital Quality Alliance, which are data
ost institutions already submit. Additionally, hospitals
ere alerted to opportunities to participate in registries, such
s the National Cardiovascular Data Registry (NCDR)–
athPCI Registry, Acute Coronary Treatment and Inter-
ention Outcomes Network (ACTION) Registry, and the
HA Get With the Guidelines program, because they have
ach developed approaches to support participating institu-
ions with data (22–24).
econd phase—participation. The second phase of the
roject was a drive for participation that began officially with
he D2B Alliance public announcement in November 2006
t the AHA Scientific Sessions. The launch of the D2B
lliance was accompanied by considerable media coverage.
rticles reached more than 200 newspapers, including a
ront-page feature in USA Today. Television coverage in-
luded the network evening news.
The launch initiated a robust appeal for hospital partic-
pation. To enroll in the D2B Alliance, hospitals completed
form online committing the institution to the goal of the
roject and signaling endorsement by senior leadership.
Table 2. Strategies for Hospitals to Reduce D2B Times
Key strategies
Activation of the catheterization laboratory by emergency medicine physicians
Establishment of a single-call system for activating the catheterization laboratory
Expectation that the catheterization team be available within 20 to 30 min of bein
Use of data monitoring and prompt data feedback to emergency department and
Senior management support and organizational environment that fosters and sust
Team-based approach from ambulance to balloon, within a culture of continuous
Optional strategy
Use of pre-hospital electrocardiogram to activate the catheterization laboratory
D2B door-to-balloon.ach hospital also named a clinician leader as a contact for phe project and agreed to complete a baseline survey of their
urrent D2B practices.
The ACC and its partners sought to enroll as many
ospitals as possible that perform primary PCI. Support for
he enrollment process was enlisted from the 39 ACC
hapters, each with a leadership structure that is governed
y a member of the ACC. The governor and chapters
ecruited their local hospitals, and a competitive spirit was
ostered among chapters that enhanced hospital enrollment.
any partners also participated actively in communicating
ith clinicians and hospitals. Emergency medicine organi-
ations played an important role in reaching their constit-
ency and encouraging participation. The announcement of
eadlines, such as the March 2007 deadline for inclusion in
he public release of the list of participating hospitals, also
elped the recruitment effort (25).
Although recruitment focused on hospitals in the U.S.,
nrollment was not nationally restricted, and there is current
epresentation from 9 other countries. Moreover, the Span-
sh Cardiology Society joined the D2B Alliance, organized
n official launch in April 2007, and is coordinating the
nrollment and engagement of all Spanish hospitals per-
orming primary PCI. Additional countries are considering
similar commitment.
Currently, approximately 1,000 hospitals are enrolled
n the D2B Alliance, representing approximately two-
hirds of the nation’s PCI hospitals and a higher percentage
f all the primary PCIs performed in the country. The
ames of these hospitals are listed on the D2B Alliance
ebsite (26). The characteristics of the hospitals enrolled in
he D2B Alliance as of July 1, 2007, in the U.S. are listed in
able 3.
hird phase—intervention. The third phase of the project,
hich began in parallel with efforts to enroll hospitals, was
he intervention. From the outset, a kit with a description of
he project and tools was made available on the D2B
lliance website. Educational sessions that disseminated
nformation about innovative approaches and provided in-
ormation about experiences at various sites were conducted.
he online community was launched in April 2007 using a
ed
terization laboratory staff
rganizational change directed at improving D2B time
improvementg pag
cathe
ains o
qualityroduct of the Institute for Healthcare Improvement, with
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102he intent of providing a venue for the exchange of infor-
ation among D2B Alliance participants. The baseline
urvey was conducted, and hospital-specific action plans
ere provided to each participating hospital on the basis of
he survey data.
Several partners have integrated the D2B Alliance into
heir activities in novel ways. Many ACC chapters have
ncorporated D2B into their annual meetings. For example,
he Michigan chapter of the ACC convened a meeting of
epresentatives from all PCI centers in the state and
eveloped a coordinated effort to implement the D2B
lliance intervention. The NCDR has promoted the D2B
lliance and is developing targeted quality improvement
ctivities to support the effort. The AHA made D2B a
ajor initiative within its Get With the Guidelines pro-
ram. The University HealthSystem Consortium included
2B in a targeted quality improvement project to improve
he timeliness of care for patients with STEMI. Some
rganizations, such as UnitedHealthcare and the BlueCross
lueShield Association, have incorporated participation as a
equirement for their Center of Excellence programs. The
Table 3. Characteristics of the Hospitals in the U.S. Enrolled
in the D2B Alliance
Characteristics n %
Total 915 100.0
Number of beds
Unknown 18 2.0
300 420 46.0
300 to 600 369 40.3
600 108 11.8
Mean (SD) 362.9 (233.6)
Ownership
Unknown 18 2.0
Government 85 9.3
Not-for-proﬁt 654 71.5
For proﬁt 158 17.3
Region
New England 32 3.5
Middle Atlantic 100 10.9
South Atlantic 167 18.3
East North Central 186 20.3
East South Central 75 8.2
West North Central 68 7.4
West South Central 121 13.2
Mountain 63 6.9
Paciﬁc 103 11.3
Teaching status
Unknown 18 2.0
Teaching 505 55.2
Non-teaching 392 42.8
Includes hospitals enrolled before July 1, 2007.
D2B door-to-balloon.HLBI and the Agency for Healthcare Research and cuality have promoted the effort through education and
onferences. Tenet and the Hospital Corporation of Amer-
ca have made D2B a core quality improvement initiative
ithin their organizations.
valuation
he D2B Alliance is designed to improve the timeliness of
rimary PCI, and the evaluation is intended to assess the
ffect of the initiative. In addition, the project is intended to
enerate knowledge about how best to disseminate and
ranslate research about health care delivery into practice.
he baseline and follow-up surveys will enable an assess-
ent of how implementation of key hospital strategies has
hanged over the course of the project. The baseline survey
as administered as close as possible to the enrollment date
ut not later than May 2007. The follow-up survey will be
dministered to hospitals approximately 1 year after enroll-
ent, ranging from January to March 2008 on the basis of
ach hospital’s enrollment date. The evaluation seeks to
nalyze the following outcomes:
Changes in the use of the evidence-based strategies
Changes in D2B times
Hospital views about the role of the D2B Alliance in
fostering changes, and remaining barriers to improve
D2B times
Multiple data sources will be used for the evaluation. The
hange in the use of evidence-based strategies will be
valuated with the baseline and follow-up surveys. For the
valuation of the change in D2B times, the data sources will
nclude the local and national registries and the data from
he Hospital Quality Alliance (27). Many of the hospitals
articipating in the D2B Alliance also participate in at least
of the national registries (i.e., NCDR, AHA Get With
he Guidelines) that are collecting data on D2B times. The
se of registries and Hospital Quality Alliance data will
llow the comparison of D2B Alliance hospitals with those
hat do not participate. Additionally, almost all of the
ospitals participating within the D2B Alliance are also
ubmitting data to the CMS for public reporting of D2B
imes. These data will provide the best opportunity to
etermine whether hospital performance has changed sub-
tantially since the project launch in November 2006. We
ill be able to compare participating and non-participating
ospitals and identify those who had the most marked
mprovement in performance. We will also work with
ospitals outside the U.S. so that they might obtain com-
arable data to similarly determine the effectiveness of the
rogram and benchmark against the progress in other
ountries.
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103ext Steps
o date, the D2B Alliance has been successful in uniting a
road-based coalition of practitioners, hospitals, and orga-
izations that have agreed to work with the ACC to
mprove D2B times. This effort employed methods that
mphasized evidenced-based strategies, minimized burdens
n the participants, and demonstrated the feasibility of
apidly launching a focused initiative to improve care on an
nternational scale.
As the next steps in this project are contemplated,
articipants and collaborating organizations have suggested
he need to facilitate more effective use of pre-hospital
lectrocardiogram capability and to improve the transfer
imes between hospitals for patients with STEMI. Thus,
here is a need to improve door-to-reperfusion therapy time
or all patients, including those that present at hospitals
ithout PCI capability. For the many patients who receive
are at hospitals that do not have PCI capability, the
ecision about treatments with fibrinolytic therapy or trans-
er for PCI must be made quickly, and there are aspects of
his care that can be improved. Currently, among those
ransferred for primary PCI, the median D2B time (door of
he first hospital to balloon at the second hospital) is 3 h
28). The next step in the D2B Alliance could be to extend
he focus to all hospitals and clinicians to ensure that all
atients with STEMI are treated as rapidly and appropri-
tely as possible, allowing the guidelines to set the stan-
ards. Ultimately, future efforts can then focus on improv-
ng time from symptom onset to hospital arrival.
There are lessons to be learned from the experience of
reating and implementing the D2B Alliance that might
ave important implications for future quality improvement
ampaigns in other areas. The D2B Alliance can provide
vidence about the success of the initiative and how best to
isseminate and translate research about health care delivery
nto practice. Lessons from this effort will be documented,
nd their generalizability to other treatments, processes, and
onditions should be tested. Without strategies that ensure
apid, effective, and widespread application of newly proven
herapies, delayed and inadequate adoption of such innova-
ions will limit the efficiency of our health care system in
aking the best use of medical knowledge.
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APPENDIX
or examples of tools that would assist clinicians and hospitals and a
eb-based survey for participating hospitals, please see the online version
f this article.
